Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia

Abstract

The level of endoglin was measured in two series in 11 patients with familial hypercholesterolemia. Significant decrease of level was found after extracorporeal elimination; it was after rheopheresis in 3 patients 28.410.74/34.375.57% (after the first and second serie) and after LDL-apheresis in 8 patients 21.229.05/17.843.20%.